Connect Biopharma Holdings Limited Current Financial Assets Measured At Fair Value Through Other Comprehensive Income
Connect Biopharma Holdings Limited (CNTB) had Current Financial Assets Measured At Fair Value Through Other Comprehensive Income of $0 as of 2024-06-30, per its 6-K filed 2024-09-05.
Discontinued › Notes › Equity
ifrs-full:CurrentFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome · last filed 2024-09-05
- 2023-06-30: Current Financial Assets Measured At Fair Value Through Other Comprehensive Income 360.98M CNY.
- 2022-12-31: Current Financial Assets Measured At Fair Value Through Other Comprehensive Income 511.25M CNY.
- 2022-06-30: Current Financial Assets Measured At Fair Value Through Other Comprehensive Income 330.67M CNY.
CNY
| Period end | Current Financial Assets Measured At Fair Value Through Other Comprehensive Income |
|---|---|
| 2023-06-30 | 360.98M CNY 6-K · filed 2023-09-12 |
| 2022-12-31 | 511.25M CNY 6-K · filed 2023-09-12 |
| 2022-06-30 | 330.67M CNY 6-K · filed 2022-09-13 |
USD
| Period end | Current Financial Assets Measured At Fair Value Through Other Comprehensive Income | Current Financial Assets Measured At Fair Value Through Other Comprehensive Income as first filed |
|---|---|---|
| 2024-06-30 | $0.00 6-K · filed 2024-09-05 | |
| 2023-12-31 | $12.65M 6-K · filed 2024-09-05 | $73.41M 20-F · filed 2024-04-16 |
| 2022-12-31 | $12.65M 20-F · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |